123 related articles for article (PubMed ID: 3413717)
21. Redirection of arachidonic acid metabolism by ICI D1542: effects on thrombus formation in the coronary artery of the anaesthetized dog.
McAuliffe SJ; Moors JA; Snow HM; Wayne M; Jessup R
Br J Pharmacol; 1993 Apr; 108(4):901-6. PubMed ID: 8485629
[TBL] [Abstract][Full Text] [Related]
22. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
[TBL] [Abstract][Full Text] [Related]
23. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
Hsieh CP; Sakai K; Bruns GC; Dage RC
J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
[TBL] [Abstract][Full Text] [Related]
24. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
Beaughard M; Brasset M; John G; Massingham R
J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
[TBL] [Abstract][Full Text] [Related]
25. Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries.
Maalej N; Folts JD
Circulation; 1996 Mar; 93(6):1201-5. PubMed ID: 8653842
[TBL] [Abstract][Full Text] [Related]
26. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
27. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
28. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Prosdocimi M; Finesso M; Tessari F; Gorio A; Languino LR; de Gaetano G; Dejana E
Thromb Res; 1985 Aug; 39(4):399-409. PubMed ID: 3840290
[TBL] [Abstract][Full Text] [Related]
29. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
Yao SK; Ober JC; Gonenne A; Clubb FJ; Krishnaswami A; Ferguson JJ; Anderson HV; Gorecki M; Buja LM; Willerson JT
Circ Res; 1993 Nov; 73(5):952-67. PubMed ID: 8403265
[TBL] [Abstract][Full Text] [Related]
30. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.
Bolli R; Ware JA; Brandon TA; Weilbaecher DG; Mace ML
J Am Coll Cardiol; 1984 Jun; 3(6):1417-26. PubMed ID: 6715702
[TBL] [Abstract][Full Text] [Related]
31. Garlic extract prevents acute platelet thrombus formation in stenosed canine coronary arteries.
DeBoer LW; Folts JD
Am Heart J; 1989 Apr; 117(4):973-5. PubMed ID: 2929414
[No Abstract] [Full Text] [Related]
32. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
33. Combination of aspirin and metoclopramide produces a synergistic antithrombotic effect in a canine model of coronary artery thrombosis.
Duval N; Grosset A; O'Connor SE
Fundam Clin Pharmacol; 1997; 11(1):57-62. PubMed ID: 9182077
[TBL] [Abstract][Full Text] [Related]
34. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
[TBL] [Abstract][Full Text] [Related]
35. Combined effect of the 5-HT2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs.
Tanaka T; Morishima Y; Watanabe K; Shibutani T; Yasuoka M; Shibano T
Cardiovasc Res; 1993 Jul; 27(7):1374-9. PubMed ID: 8252602
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor.
Torr SR; Haskel EJ; VonVoigtlander PF; Bergmann SR; Abendschein DR
J Am Coll Cardiol; 1991 Dec; 18(7):1804-10. PubMed ID: 1960333
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 and epinephrine participate in cyclical reduction of coronary blood pressure and flow.
Uchida Y; Yoshimoto N; Murao S
Jpn Heart J; 1978 Mar; 19(2):281-96. PubMed ID: 650909
[TBL] [Abstract][Full Text] [Related]
38. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries.
Demrow HS; Slane PR; Folts JD
Circulation; 1995 Feb; 91(4):1182-8. PubMed ID: 7850957
[TBL] [Abstract][Full Text] [Related]
39. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
[TBL] [Abstract][Full Text] [Related]
40. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis.
Folts J
Circulation; 1991 Jun; 83(6 Suppl):IV3-14. PubMed ID: 2040070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
